Page last updated: 2024-10-23

betahistine and Conductive Hearing Loss

betahistine has been researched along with Conductive Hearing Loss in 1 studies

Betahistine: A histamine analog and H1 receptor agonist that serves as a vasodilator. It is used in MENIERE DISEASE and in vascular headaches but may exacerbate bronchial asthma and peptic ulcers.
betahistine : An aminoalkylpyridine that is pyridine substituted by a 2-(methylamino)ethyl group at position 2. It acts as a histamine agonist and a vasodilator, and is thought to improve the microcirculation of the labyrinth, resulting in reduced endolymphatic pressure. It is used (generally as the hydrochloride or mesylate salt) to reduce the symptoms of vertigo, tinnitus, and hearing loss associated with Meniere's disease.

Research Excerpts

ExcerptRelevanceReference
"In 12 patients there were recognized conductive hearing loss and they were excluded from therapy of betahistine."2.73[Therapy of tinnitus in children]. ( Drobik-Wasiewicz, K; Gryczyńska, D; Kotecki, M; Malicka, M, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gryczyńska, D1
Drobik-Wasiewicz, K1
Malicka, M1
Kotecki, M1

Trials

1 trial available for betahistine and Conductive Hearing Loss

ArticleYear
[Therapy of tinnitus in children].
    Otolaryngologia polska = The Polish otolaryngology, 2007, Volume: 61, Issue:5

    Topics: Adolescent; Audiometry; Betahistine; Child; Hearing Loss, Conductive; Humans; Tinnitus; Treatment Ou

2007